In the following presentations, we will be sharing some of our most valuable findings on this essential and transformative topic of our time:

🎤 In the annual intensive course for talented young clinicians and researchers, our center director, Professor Tine Jess, will provide a presentation on epidemiology, immunopathogenesis, and their relevance to therapeutics. She also gives a Tandem Talk with Mathieu Uzzan on B cells as a preclinical biomarker in IBD in the scientific programme of the congress.

🎤 At the congress, MD, PhD Mette Julsgaard (PREDICT research associate) will present her research on pregnancy and infant outcomes after in utero exposure to JAK inhibitors in IBD. Moreover, she will be chairing a session on IBD in special populations.

🎤 Dr. Jonas Rudbæk will reveal insights from his latest study that for the first time globally detects changes in the newborn metabolome of individuals who later develop IBD.

🎤 PhD student Olivia Mariella will talk about the association between the maternal intake of ultra-processed foods during pregnancy and how it affects the offspring’s risk of IBD.

🎤 PhD student Alice Fracchia will reveal why the maternal environment captured by the neonatal metabolome is not predictive of later IBD.

🎤 MD, PhD student Mads Lie will share conclusions from his to date largest population-based study on how to predict responses to anti-TNF drugs like infliximab or adalimumab.

🎤 Our research associate, Assistant Professor Adam Faye will provide evidence of a significant mortality benefit of elective colectomy in Ulcerative Colitis compared with continuing medical therapy. 

🎤 Finally, as recipient of The ECCO Young Researcher Award 2026, Associate Professor Aleksejs Sazonovs will present insights from his research on future screening strategies of IBD. In contrast to traditional single-timepoint testing, he proposes a hierarchical stratification strategy to efficiently predict IBD prior to symptom onset and scale interventions once validated.

PREDICT is also widely represented at ECCO’26 with several poster presentations

👉 Associate Professor Lone Larsen will demonstrate real-world treatment patterns and persistence among patients with moderately to severely active Ulcerative Colitis initiating mirikizumab.

👉 Assistant Professor Dr. Filip Ottosson will present pre-diagnostic changes that has been observed in the metabolome of IBD.

👉 Research Assistant Michelle Sollok will clarify the role of high predictive performance, cohort enrichment and intervention efficacy for Crohn's disease prevention trials.

👉 Research Assistant Gabriela Ciobotaru will reveal her findings on the association between maternal fish intake during pregnancy and the offspring’s risk of metabolic profile alterations and IBD.

👉 Postdoc Serife Ayten will show how multi-omic signatures of NOVA food groups associates with risk of IBD. 

👉 Dr. Kaustubh Sanjay Chakradeo will illuminate how prevalence of IBD is related to rapid urbanisation in rural India.

👉 PhD student Christina Lykke Balmer will illustrate that the risk of IBD is not influenced by early-life animal exposure. 

👉 Research Assistant Hunter R. Moran will talk about his investigations into the socioeconomic impact of pediatric IBD.

Being part of ECCO is both an inspiration and a responsibility, ensuring that the findings of research translate into clinical practice across the world. 

See you there! Let’s raise the roof of holistic IBD care together!